Tech, Software Sell Off… And The Impact On Private Credit 2/3/26
CNBC's "Fast Money"
00:00
Novo Nordisk Sales Warning and Obesity Drug Headwinds
Panel and BMO's Evan Siegerman discuss Novo's guidance cut, U.S. pricing pressure, and implications for peers.
Play episode from 23:43
Transcript
